Financials

News Discussions Technicals Seasonals

ALVET fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

TheraVet SA is a veterinary biotech company, which specializes in the development and production of treatments for osteoarticular diseases in cats, dogs, and horses. Its products include Biocera-Vet and Visco-Vet. The company was founded by Enrico Jose Adolfo Bastianelli on November 21, 2017 and is headquartered in Gosselies, Belgium.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

ALVET does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company